D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 88 Citations 37,012 499 World Ranking 8232 National Ranking 4414

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Internal medicine
  • Gene

The scientist’s investigation covers issues in Internal medicine, Cancer, Melanoma, Clinical trial and Gastroenterology. His biological study spans a wide range of topics, including Placebo, Gynecology, Surgery and Oncology. Frank L. Meyskens is interested in Cancer prevention, which is a branch of Cancer.

He works mostly in the field of Cancer prevention, limiting it down to topics relating to Lung cancer and, in certain cases, Epidemiology and Relative risk, as a part of the same area of interest. The concepts of his Melanoma study are interwoven with issues in Molecular biology, In vitro, Karyotype and Transcription factor. His biological study spans a wide range of topics, including Oral administration, Adverse effect, Taxane and Confidence interval.

His most cited work include:

  • EFFECTS OF A COMBINATION OF BETA CAROTENE AND VITAMIN A ON LUNG CANCER AND CARDIOVASCULAR DISEASE (3031 citations)
  • Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). (1629 citations)
  • Vitamin E and the Risk of Prostate Cancer: The Selenium and Vitamin E Cancer Prevention Trial (SELECT) (1103 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Internal medicine, Melanoma, Cancer, Cancer research and Oncology. His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology, Placebo and Endocrinology. His Melanoma research incorporates elements of Molecular biology, Cell culture, Immunology and Pathology.

His Molecular biology study combines topics from a wide range of disciplines, such as Cell and Clonogenic assay. Cancer connects with themes related to Surgery in his study. His Oncology study integrates concerns from other disciplines, such as Breast cancer, Disease and Chemotherapy.

He most often published in these fields:

  • Internal medicine (38.49%)
  • Melanoma (28.05%)
  • Cancer (20.89%)

What were the highlights of his more recent work (between 2011-2021)?

  • Internal medicine (38.49%)
  • Melanoma (28.05%)
  • Cancer research (17.99%)

In recent papers he was focusing on the following fields of study:

Frank L. Meyskens mainly focuses on Internal medicine, Melanoma, Cancer research, Oncology and Cancer. His Internal medicine research incorporates themes from Gastroenterology and Placebo. The various areas that Frank L. Meyskens examines in his Melanoma study include Reactive oxygen species, Epidemiology, Immunology and Skin cancer.

His Cancer research research includes elements of Cell culture, Gene knockdown and Kinase, MAPK/ERK pathway. His studies in Cancer integrate themes in fields like Aspirin, Asymptomatic and Disease. His Cancer prevention research is multidisciplinary, relying on both Gerontology and Family medicine.

Between 2011 and 2021, his most popular works were:

  • Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy. (303 citations)
  • Estimates of benefits and harms of prophylactic use of aspirin in the general population (244 citations)
  • Prevention and early detection of prostate cancer (223 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Internal medicine
  • Gene

Frank L. Meyskens spends much of his time researching Internal medicine, Cancer, Oncology, Gastroenterology and Melanoma. His research integrates issues of Placebo and Surgery in his study of Internal medicine. His study in Cancer is interdisciplinary in nature, drawing from both Aspirin and Gerontology.

His research in Gastroenterology intersects with topics in Endocrinology, Hazard ratio, Confidence interval, Proportional hazards model and Vitamin E. His Melanoma study combines topics in areas such as Metastasis, Epidemiology, Immunology and Skin cancer. His Cancer prevention research includes themes of Precision medicine and Comparative effectiveness research.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

EFFECTS OF A COMBINATION OF BETA CAROTENE AND VITAMIN A ON LUNG CANCER AND CARDIOVASCULAR DISEASE

Gilbert S. Omenn;Gary E. Goodman;Gary E. Goodman;Mark D. Thornquist;John Balmes.
The New England Journal of Medicine (1996)

4458 Citations

Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Scott M. Lippman;Eric A. Klein;Eric A. Klein;Phyllis J. Goodman;M. Scott Lucia.
JAMA (2009)

2525 Citations

Vitamin E and the Risk of Prostate Cancer: The Selenium and Vitamin E Cancer Prevention Trial (SELECT)

Eric A. Klein;Ian M. Thompson;Catherine M. Tangen;John J. Crowley.
JAMA (2011)

1932 Citations

Risk Factors for Lung Cancer and for Intervention Effects in CARET, the Beta-Carotene and Retinol Efficacy Trial

Gilbert S. Omenn;Gary E. Goodman;Mark D. Thornquist;John Balmes.
Journal of the National Cancer Institute (1996)

1507 Citations

Polyamines and cancer: old molecules, new understanding

Eugene W. Gerner;Frank L. Meyskens.
Nature Reviews Cancer (2004)

1218 Citations

Reactive Oxygen Species: A Breath of Life or Death?

John P. Fruehauf;Frank L. Meyskens.
Clinical Cancer Research (2007)

1089 Citations

Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement

Jack Cuzick;Florian Otto;Florian Otto;John A Baron;Powel H Brown.
Lancet Oncology (2009)

819 Citations

Diagnosis and Treatment of Early Melanoma: NIH Consensus Development Panel on Early Melanoma

Lowell A. Goldsmith;Frederic B. Askin;Alfred E. Chang;Cynthia Cohen.
JAMA (1992)

672 Citations

Development of difluoromethylornithine (DFMO) as a chemoprevention agent.

Frank L. Meyskens;Eugene W. Gerner.
Clinical Cancer Research (1999)

631 Citations

Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy.

Halle C F Moore;Joseph M. Unger;Kelly Anne Phillips;Frances Boyle;Frances Boyle.
The New England Journal of Medicine (2015)

569 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Frank L. Meyskens

Scott M. Lippman

Scott M. Lippman

University of California, San Diego

Publications: 108

Waun Ki Hong

Waun Ki Hong

The University of Texas MD Anderson Cancer Center

Publications: 73

David S. Alberts

David S. Alberts

University of Arizona

Publications: 66

Demetrius Albanes

Demetrius Albanes

National Institutes of Health

Publications: 56

Eugene W. Gerner

Eugene W. Gerner

University of Arizona

Publications: 49

Reuben Lotan

Reuben Lotan

The University of Texas MD Anderson Cancer Center

Publications: 46

Gilbert S. Omenn

Gilbert S. Omenn

University of Michigan–Ann Arbor

Publications: 45

Robert A. Casero

Robert A. Casero

Johns Hopkins University School of Medicine

Publications: 43

Walter C. Willett

Walter C. Willett

Harvard University

Publications: 42

Meir J. Stampfer

Meir J. Stampfer

Harvard University

Publications: 42

Mary J.C. Hendrix

Mary J.C. Hendrix

Northwestern University

Publications: 39

Gary J. Kelloff

Gary J. Kelloff

National Institutes of Health

Publications: 39

J. Jack Lee

J. Jack Lee

The University of Texas MD Anderson Cancer Center

Publications: 39

Ian M. Thompson

Ian M. Thompson

The University of Texas Health Science Center at San Antonio

Publications: 37

Vernon E. Steele

Vernon E. Steele

National Institutes of Health

Publications: 37

Robert M. Russell

Robert M. Russell

Tufts University

Publications: 36

Trending Scientists

Farinaz Koushanfar

Farinaz Koushanfar

University of California, San Diego

Muhammad Kazmi

Muhammad Kazmi

Ericsson (Sweden)

Wilhelmus M. M. Kessels

Wilhelmus M. M. Kessels

Eindhoven University of Technology

Eiichi Tamiya

Eiichi Tamiya

Osaka University

Suk-Joong L. Kang

Suk-Joong L. Kang

Korea Advanced Institute of Science and Technology

Jurrien Dean

Jurrien Dean

National Institutes of Health

Helen E. Roy

Helen E. Roy

Anglia Ruskin University

Jun Aoyama

Jun Aoyama

University of Tokyo

Ian Clark-Lewis

Ian Clark-Lewis

University of British Columbia

Jeffrey E. Pessin

Jeffrey E. Pessin

Albert Einstein College of Medicine

James R. Alfano

James R. Alfano

University of Nebraska–Lincoln

Anders Meibom

Anders Meibom

École Polytechnique Fédérale de Lausanne

Xunchang Zhang

Xunchang Zhang

Agricultural Research Service

Michel Jouvet

Michel Jouvet

Claude Bernard University Lyon 1

Martin Euwema

Martin Euwema

KU Leuven

Thomas Hale

Thomas Hale

University of Oxford

Something went wrong. Please try again later.